Back to top
more

Cardlytics (CDLX)

(Delayed Data from NSDQ)

$4.28 USD

4.28
26,724

0.00 (0.00%)

Updated Aug 25, 2026 04:00 PM ET

After-Market: $4.30 +0.02 (0.47%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 33% (166 out of 246)

Industry: Technology Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Cardlytics, Inc. (CDLX) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 120.00% and 13.89%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Cardlytics, Inc. (CDLX) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Cardlytics, Inc. (CDLX) Moves to Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Cardlytics, Inc. (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Cardlytics, Inc. (CDLX) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 47.83% and 11.23%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Cardlytics, Inc. (CDLX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Fiserv (FISV) to Post Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Fiserv's (FISV) second-quarter 2019 results to reflect revenue growth and better operating performance.

Zacks Equity Research

IQVIA (IQV) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

IQVIA's (IQV) second-quarter 2019 results are likely to benefit from continued market penetration of analytics and technology-enabled offerings across the company's TAS and R&DS businesses.

Zacks Equity Research

Here's Why Momentum Investors Will Love Cardlytics, Inc. (CDLX)

by Zacks Equity Research

Does Cardlytics, Inc. (CDLX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Cardlytics, Inc. (CDLX) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

Cardlytics, Inc. (CDLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

All You Need to Know About Cardlytics, Inc. (CDLX) Rating Upgrade to Strong Buy

by Zacks Equity Research

Cardlytics, Inc. (CDLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.